Luai Zarour, MD
Surgery · Gresham, ORNPI 1912273236
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 60.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $7,109 and has fallen 96.7% since, to $233 in 2025.
Across 55 payments — averaging $161.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- W. L. Gore & Associates, Inc.$2K
- BD$788
- Davol Inc.$590
- Conmed Corporation$125
- Sanara Medtech Inc.$125
- plus $361 from 6 others
What the payments were for
- Travel & lodging$2,52028%
- Food & beverage$2,34826%
- Education$4,00045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $5,340 |
| W. L. Gore & Associates, Inc. | 16 | $1,539 |
| BD | 6 | $788 |
| Davol Inc. | 12 | $590 |
| Conmed Corporation | 1 | $125 |
| Sanara Medtech Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Vertex | 1 | $103 |
| Johnson & Johnson | 2 | $69 |
| Baxter Healthcare | 1 | $25 |
| KCI USA, Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,000
- Da Vinci Surgical System$1,067
- GORE BIO-A Tissue Reinforcement$922
- Phasix Mesh$687
- GORE ENFORM Preperitoneal Biomaterial$150
- GORE SYNECOR Biomaterial$150
- AIRSEAL$125
- CellerateRx$125
- FARXIGA$125
- JOURNAVX$103
How this compares
$8,868 in reported general payments places this provider in the 80th percentile of 386 surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 47 | $127 |
| Oxycodone Hcl | 63 | $115 |
| Gabapentin | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other surgery in Gresham
- Robert AzarGresham$14K
- Robert MartindalePortland$795K
- Edward BoyleBend$618K
- Sean OrensteinPortland$480K
- Vahagn NikolianPortland$277K
- Timothy BeardBend$211K
- Ann RustHermiston$173K
- Sabrina DrexelPortland$170K
- Avishai MeyerPortland$159K
- Farah HusainPortland$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.